| scholarly article | Q13442814 |
| P2093 | author name string | Gui-shuang Ying | |
| Maureen G Maguire | |||
| David R Hardten | |||
| Roni M Shtein | |||
| Penny A Asbell | |||
| Maxwell Pistilli | |||
| Loretta B Szczotka-Flynn | |||
| Meng C Lin | |||
| Dry Eye Assessment and Management Study Research Group | |||
| P2860 | cites work | Interval estimation for the difference between independent proportions: comparison of eleven methods | Q56475155 |
| Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye | Q82285158 | ||
| Short-term consumption of oral omega-3 and dry eye syndrome | Q86711173 | ||
| A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction | Q24624909 | ||
| The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis) | Q24649593 | ||
| Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Q29615694 | ||
| The economic burden of dry eye disease in the United States: a decision tree analysis | Q34147677 | ||
| The core mechanism of dry eye disease is inflammation | Q34510429 | ||
| Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. | Q35564285 | ||
| Oral omega-3 fatty acid treatment for dry eye in contact lens wearers | Q35568067 | ||
| A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms. | Q35980900 | ||
| Challenges and pitfalls in clinical trials of treatments for dry eye. | Q36639883 | ||
| Regression analysis for correlated data | Q36764238 | ||
| Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes | Q37155783 | ||
| A randomized controlled trial of omega-3 fatty acids in dry eye syndrome | Q37417825 | ||
| Minimal clinically important difference for the ocular surface disease index | Q37672025 | ||
| Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life | Q37715859 | ||
| Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial. | Q38447815 | ||
| TFOS DEWS II Epidemiology Report | Q38652994 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. | Q40462210 | ||
| Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3). | Q46401944 | ||
| Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial | Q46413905 | ||
| Effect of oral omega-3 Fatty Acid supplementation on contrast sensitivity in patients with moderate meibomian gland dysfunction: a prospective placebo-controlled study | Q47715274 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1681-1690 | |
| P577 | publication date | 2018-04-13 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease | |
| P478 | volume | 378 |
| Q59809485 | Q59809485 |
| Q64089977 | Q64089977 |
| Q64072411 | A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease |
| Q89875479 | Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at Baseline in the Dry Eye Assessment and Management Study |
| Q92460544 | Changes in Tear Lipid Layer Thickness and Symptoms Following the Use of Artificial Tears with and Without Omega-3 Fatty Acids: A Randomized, Double-Masked, Crossover Study |
| Q98613385 | Climatic and Environmental Correlates of Dry Eye Disease Severity: A Report From the Dry Eye Assessment and Management (DREAM) Study |
| Q89906657 | Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial |
| Q95729513 | Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study |
| Q92824372 | Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits |
| Q64060184 | Dry Eye Disease: Consideration for Women's Health |
| Q90392513 | Efficacy of topical microemulsion of fatty acids of the ω-3 series on the sub-epithelial corneal nerves regeneration after epithelium-off corneal collagen cross-linking for keratoconus |
| Q90035249 | Explanatory Model of Dry Eye Disease Using Health and Nutrition Examinations: Machine Learning and Network-Based Factor Analysis From a National Survey |
| Q89536542 | Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies |
| Q93341813 | Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Wo |
| Q90182793 | Ocular Manifestations of Rheumatoid Arthritis: Implications of Recent Clinical Trials |
| Q90371647 | Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT |
| Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q59809603 | Omega-3 supplements for dry eye |
| Q64903176 | Preliminary Validation of a Food Frequency Questionnaire to Assess Long-Chain Omega-3 Fatty Acid Intake in Eye Care Practice. |
| Q55515186 | The Eye, Oxidative Damage and Polyunsaturated Fatty Acids. |
| Q64090005 | Top studies relevant to primary care from 2018: From PEER |
Search more.